Thanks, Eric and good morning, everyone. Let’s go to Slide 4. As Eric mentioned, we outperformed our guidance for the first quarter across revenue, margin and adjusted earnings per share. Now all comparisons I will discuss will be against the prior year period unless stated otherwise. In the first quarter, organic sales declined 1% as we faced difficult comps in our semiconductor, agriculture, chemical and energy businesses, which more than offset positive results in space, defense and municipal water facing businesses. We continued to see resilient demand all in for IDEX, with organic orders up 1% and backlog building by about $60 million. Adjusted EBITDA margin declined 50 basis points to 25.5%, given year-over-year volume deleverage and near-term margin dilution from our acquisition of Mott. And these were partially offset by positive price/cost and productivity, including our announced platform optimization efforts. First quarter 2025 adjusted EPS of $1.75 came in $0.10 better than the high end of our guided range, given better-than-expected sales and margins across segments and timing of corporate costs, most notably share-based compensation. We generated $91 million of free cash flow in the quarter, which included short-term investments in working capital to support higher sales in the second quarter as well as some modest purchasing ahead of inventory, intended to slow tariff impact. Additionally, we deployed $50 million to repurchase added shares in the first quarter, and we have $490 million left with our current authorization. I’m on Slide 5. Turning to the drivers of our adjusted EBITDA, a decline in volume resulted in an $8 million reduction flowing through our prior year adjusted gross margin rate. We additionally experienced unfavorable overhead leverage, which was more than offset by platform optimization savings and favorable price/cost, which was accretive to margins. Acquisitions, divestitures and FX benefited adjusted EBITDA by $3 million. Now quickly, some color on our results by segment. I’m on Slide 6. In HST, organic sales of first quarter declined 1%, while our organic orders actually increased 3%. We are seeing solid activity in our Performance Pneumatics Group, driven by growth in data center power solutions and in Space & Defense with a number of our optics businesses. We see steady trends in life sciences with an uptick in analytical instrumentation, more than offsetting lower DNA sequencing orders. Our semiconductor business, specifically where we provide solutions that support wafer fabrication faces headwinds. Adjusted EBITDA margins of 25.6%, was slightly better than we anticipated, primarily due to benefits from higher-than-expected volumes in the first quarter. Turning to Slide 7. In FMT, organic sales declined 4% and organic orders declined 3%. While we continue to see relative strength in municipal water and downstream energy markets and relative stability in our core industrial markets, we are also experiencing near-term pressures in our chemicals and ag businesses. Finally, our business supporting pure water applications within semiconductor fabs has slowed. Adjusted EBITDA margin of 32.8% declined 80 basis points as volume deleverage was only partially offset by price, cost and productivity improvements, including platform optimization savings. I’m on Slide 8. FSD turned under the solid quarter, with organic sales increasing 5% and organic orders up 2%. Our Fire & Safety business continues to benefit from both strong OEM demand and adoption of integrated solutions. BAND-IT experienced growth in energy with aerospace remaining stable. We continue to build upon our leadership position in dispensing their overall global trends are stable and auto remains special. Adjusted EBITDA margin of 29.4% increased 50 basis points due to favorable volume leverage, price cost and productivity. Now please turn to Slide 9 for our updated full year and second quarter guidance. We are maintaining our full year organic growth guidance range of 1% to 3% and adjusted EPS of $8.10 to $8.45. Although the situation is still evolving, we believe we can fully absorb the impact of the tariffs introduced this year based on our current assumptions. I will provide our detailed tariff assumptions on the next slide. We expect to fully mitigate tariff pressure largely through incremental pricing actions. We are navigating a fluid and uncertain environment and the impact of this on underlying demand is challenging to predict, particularly in the short lead time or rapid replenishment areas of our business. While we have not observed any immediate signs of demand softening through April, we acknowledge that it could manifest as the year plays out given policy-driven uncertainty. We have proactively identified an additional $20 million of savings that we are deploying against scenarios of up to 3% to 4% back half volume pressure. For the second quarter, we anticipate organic revenue growth of flat to 2%. We expect second quarter adjusted EBITDA margin to be between 26.5% to 27% up 100 basis points or more sequentially on higher volumes, positive price and greater traction on our platform optimization and delayering savings. This generates expected second quarter adjusted EPS of $1.95 to $2.05. Please turn to Slide 10, which outlines our tariff exposure as it stands today. We expect tariffs to drive $100 million of annualized impact based on 2025 volumes with two-third of that amount to be recognized in 2025. On an annualized basis, we expect that tariffs will add 5% to 6% inflation to our cost of goods sold which can be offset by price increases of 3% to 4%. I want to take a moment to emphasize how IDEX strives during times of disruption. In particular, IDEX benefits from its local-to-local manufacturing footprint, the flexibility provided by its 80/20 principles and the strength of its long-standing customer partnerships. Additionally, as Eric previously mentioned, we have the ability to adapt our technology to new applications, which further positions us for success. Now I’d like to pass it back to Eric.